FDA approves Botox competitor

By Becker's Hospital Review - Healthcare News in Becker's Hospital Review, Channels, Featured
September 9, 2022

The FDA approved Revance Therapeutics’ Daxxify, an anti-wrinkle drug and Botox competitor, Sept. 7.

Read the full post on Becker's Hospital Review - Healthcare News

Becker's Hospital Review - Healthcare News